Abstract
A series of amphiphilic N-(2-hydroxy)propyl-3-trimethylammonium-chitosan-cholic acid (HPTA-CHI-CA) polymers were synthesized by grafting cholic acid (CA) and glycidyltrimethylammonium chloride onto chitosan. The self-assembly behavior of HPTA-CHI-CA was studied by fluorescence technique. The polymers were able to self-assemble into NPs in phosphate buffered saline with a critical aggregation concentration (CAC) in the range of 66–26 mg/L and the CAC decreased with the increasing of the degree of substitution (DS) of CA. The size of cationic HPTA-CHI-CA NPs ranges from 170 to 220 nm (PDI < 0.2). It was found that doxorubicin (DOX) could be encapsulated into HPTA-CHI-CA NPs based on self-assembly. The drug loading content and efficiency varies depending on the DS of CA and feeding ratio of DOX to polymer. In vitro release studies suggested that DOX released slowly from HPTA-CHI-CA NPs without any burst initial release. Besides, the confocal microscopic measurements indicated that DOX-HPTA-CHI-CA NPs could easily be uptaken by breast cancer (MCF-7) cells and release DOX in cytoplasm. Anti-tumor efficacy results showed that DOX-HPTA-CHI-CA NPs have a significant activity of inhibition MCF-7 cells growth. These results suggest cationic HPTA-CHI-CA may have great potential for anticancer drug delivery.
Similar content being viewed by others
References
Boddohi S, Moore N, Johnson PA, Kipper MJ (2009) Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan. Biomacromolecules 10:1402–1409
Guo S, Qiao Y, Wang W, He H, Deng L, Xing J, Xu J, Liang XJ, Dong A (2010) Poly(ε-caprolactone)-graft-poly(2-(N,N-dimethylamino) ethyl methacrylate) nanoparticles: pH dependent thermo-sensitive multifunctional carriers for gene and drug delivery. J Mater Chem 20:6935–6941
Huang CK, Lo CL, Chen HH, Hsiue GH (2007) Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater 17:2291–2297
Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41:2971–3010
Kumar M, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017–6084
Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY (1998) Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 51:213–220
Lee ALZ, Wang Y, Cheng HY, Pervaiz S, Yang YY (2009) The co-delivery of paclitaxel and herceptin using cationic micellar nanoparticles. Biomaterials 30:919–927
Li T, Longobardi L, Granero-Molto F, Myers TJ, Yan Y, Spagnoli A (2010) Use of glycol chitosan modified by 5β-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis. J Control Release 144:101–108
Liu XM, Yang YY, Leong KW (2003) Thermally responsive polymeric micellar nanoparticles self-assembled from cholesteryl end-capped random poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide): synthesis, temperature sensitivity, and morphologies. J Colloid Interface Sci 266:295–303
Liu SQ, Tong YW, Yang YY (2005) Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide-co-glycolide) with varying compositions. Biomaterials 26:5064–5074
Liu F, Feng L, Zhang L, Zhang X, Zhang N (2013) Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel. Int J Pharm 451:41–49
Mao SR, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62:12–27
Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC (2008) Hydrophobically modified glycol chitosan nanoparticles- encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127:208–218
Oh NM, Oh KT, Baik HJ, Lee BR, Lee AH, Youn YS, Lee ES (2010) A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation. Colloids Surf B Biointerfaces 78:120–126
Pan Z, Gao Y, Heng L, Liu Y, Yao G, Wang Y, Liu Y (2013) Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery. Carbohydr Polym 94:394–399
Peer D, Karp JM, Hong S, FaroKhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760
Qiu LY, Bae YH (2007) Self-assembled polyethylenimine-graft- poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. Biomaterials 28:4132–4142
Termsarasab U, Cho HJ, Kim DH, Chong S, Chung SJ, Shim CK, Moon HT, Kim DD (2013) Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery. Int J Pharm 441:373–380
Tian HY, Deng C, Lin H, Sun JR, Deng MX, Chen XS, Jing XB (2005) Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterization. Biomaterials 26:4209–4217
Tseng YC, Mozumdar S, Huang L (2009) Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 61:721–731
Van Vlerken LE, Amiji MM (2006) Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 3:205–216
Wang Y, Gao SJ, Ye WH, Yoon HS, Yang YY (2006) Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 5:791–796
Wang XY, Zhang L, Wei XH, Wang Q (2013) Molecular dynamics of paclitaxel encapsulated by salicylic acid-grafted chitosan oligosaccharide aggregates. Biomaterials 34:1843–1851
Xiong XB, Uludag H, Lavasanifar A (2009) Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 30:242–253
Zhang C, Qu GW, Sun YJ, Wu XJ, Yao ZL, Guo QL, Ding QO, Yuan ST, Shen ZL, Ping QE, Zhou HP (2008) Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233–1241
Zhang A, Zhang Z, Shi F, Ding J, Xiao C, Zhuang X, He C, Chen L, Chen X (2013a) Disulfide crosslinked PEGylated starch micelles as efficient intracellular drug delivery platforms. Soft Matter 9:2224–2233
Zhang L, Yao J, Zhou J, Wang T, Zhang Q (2013b) Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm 441:654–664
Zhao SH, Wu XT, Guo WC, Du YM, Yu L, Tang J (2010) N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34. Int J Pharm 393:269–273
Zhou C, Gao W, Lu G, Ding J, Wu X, Huang X, Chen J, Liu M, Jiang J, Wu H (2013) Preparation, characterization and in vitro release of microparticles based on dextran-rosuvastatin conjugate. Carbohydr Polym 96:156–162
Zhu JL, Cheng H, Jin Y, Cheng SX, Zhang XZ, Zhuo RX (2008) Novel polycationic micelles for drug delivery and gene transfer. J Mater Chem 18:4433–4441
Zhu CH, Jung S, Luo SB, Meng FH, Zhu XL, Park TG, Zhong ZY (2010) Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 31:2408–2416
Acknowledgments
This work was supported by National Natural Science Foundation of China Grant 81072405, Zhejiang Provincial Natural Science Foundation Grants R2100528 and LY12H31003, and Zhejiang Provincial Program for the Cultivation of High level Innovative Health talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
You, J., Li, W., Yu, C. et al. Amphiphilically modified chitosan cationic nanoparticles for drug delivery. J Nanopart Res 15, 2123 (2013). https://doi.org/10.1007/s11051-013-2123-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-013-2123-2